Recently, the m6A regulator signature (YTHDC2 and ALKBH5) [18] and m6A regulators (YTHDC2 and IGF2BP3) signature [51] were shown to have good predictive performance for OS in CRC. This evidence concerns the gene YTHDC2 and colorectal carcinoma.